American scientists have concluded that aspirin and other medicines similar kind may protect brain cells from death in Alzheimer's disease. The acquired findings open up great perspectives in the study of successful methods of combating neurodegenerative diseases.
American scientists from the Institute of Johns Hopkins in Baltimore came to the conclusion that aspirin and other drugs based on salicylic acid can be perfectly used in the treatment of Alzheimer's disease and other neurodegenerative diseases, reports NDTV. Thus, the study demonstrated that the decomposition products of aspirin in the blood prevent the death of brain cells.
This effect happens because aspirin binds to the enzyme called GAPDH, which plays a major role in the development of dementia. "The enzyme GAPDH, which we have long believed involved exclusively in the metabolism of glucose in the body, was one of the participants in intercellular "communication". Our work demonstrates that this protein can be influenced by derivatives of salicylic acid and to prevent the development of various diseases of the brain," announced 1 of the co-authors of the scientific work of Solomon Snyder.
Considering the opinion of the researchers, the study of the action of salicylic acid and its derivatives will continue to create a successful methods of treating many diseases that destroy the brain. Namely, aspirin and other products can be replaced of rare and expensive drugs that are currently used in Alzheimer's disease, Parkinson's and many other.
Earlier researchers found that aspirin reduces the risk of developing cancer. Experience has shown that those ladies who took the medication every day, 20% less likely to become ill with ovarian cancer.
sections: Society, World News